• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
Company Encyclopedia
View More
name
Penghua CSI HK Connect Health Care Composite ETF
513700.SH
Shareholder
Ownership%OwnedShare ChgReport Date
No Data
News
View More

Hong Kong unveils its first blueprint to develop Chinese medicine sector

Hong Kong has launched its first blueprint for developing the Chinese medicine sector, aiming to enhance practitioner competence and product standards. The "Chinese Medicine Development Blueprint" covers services, professional development, cultural inheritance, and global expansion, with eight goals and 20 actions outlined. The initiative seeks to integrate Chinese and Western medicine, improve healthcare quality, and position Hong Kong as a global leader in Chinese medicine. The plan includes regulatory amendments and collaboration pathways, with the first Chinese Medicine Hospital opening in Tseung Kwan O.

南华早报·12/18/2025 15:05
南华早报·12/18/2025 15:05

Hong Kong Stock Movement: ASCLETIS-B's buyback failed to boost confidence, with the stock price falling 11.02% against the trend

ASCLETIS-B fell 11.02%; CanSino Biologics fell 5.86%, with a transaction volume of HKD 937 million; BeiGene fell 7.15%, with a transaction volume of HKD 925 million; Innovent Biologics fell 3.99%, with a transaction volume of HKD 853 million; Kelun-Biotech fell 7.66%, with a market value of HKD 94 billion

HK Stock Movers Tracker·12/15/2025 13:51
HK
01672
+2.93%
HK Stock Movers Tracker·12/15/2025 13:51
HK
01672
+2.93%
© 2025 Longbridge|Disclaimer